Article
Real-world effectiveness of sofosbuvir-based treatment regimens for chronic hepatitis C genotype 3 infection: Results from the multicenter German hepatitis C cohort (GECCO-03).
Journal of medical virology - 1 Feb 2018
Wehmeyer Malte H, Ingiliz Patrick, Christensen Stefan, Hueppe Dietrich, Lutz Thomas, Simon Karl Georg, Schewe Knud, Boesecke Christoph, Baumgarten Axel, Busch Heiner, Rockstroh Juergen, Schmutz Guenther, Kimhofer Torben, Berger Florian, Mauss Stefan, Schulze Zur Wiesch Julian
Abstract excerpt
There are limited data regarding the real world effectiveness of direct acting antivirals (DAA) for the therapy of chronic genotype 3 hepatitis C virus (HCV) infection. All HCV genotype 3 infected patients from the German hepatitis C cohort (GECCO), which is a prospective database of nine German hepatitis C treatment centers, were included in the study. Three hundred forty-two chronically infected HCV genotype 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.